Cargando…
Cardiac resynchronization therapy defibrillator: de novo implant in a COVID-19 patient by an echo-guided axillary venous approach
The COVID-19 pandemic has seriously revolutionized the management of patients who need an implanted cardiac implantable electronic device. We report, for the first time, a successful cardiac resynchronization therapy defibrillator implantation procedure in an 82-year-old man affected by COVID-19, re...
Autores principales: | Agea, Aldo, Bellino, Maria C, Gianfrancesco, Domenico, Palma, Francesco, Carpagnano, Giuseppe A, Torraco, Rita MR, Marino, Maria M, Persichella, Paola, Zingaro, Sebastiano, Siena, Fabio, Di Tullio, Roberto, Deluca, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245564/ https://www.ncbi.nlm.nih.gov/pubmed/35735185 http://dx.doi.org/10.2217/fca-2021-0055 |
Ejemplares similares
-
Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010) -
Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021) -
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021) -
One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021) -
Left axillary active can positioning markedly reduces defibrillation threshold of a transvenous defibrillator failing to defibrillate at maximum output
por: Mitra, Raman L.
Publicado: (2018)